{"meta":{"query_hash":"7f710f35552f","filters":{"venue":"Bali Dermatology Venereology and Aesthetic Journal"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7f710f35552f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Bali+Dermatology+Venereology+and+Aesthetic+Journal"},"results":[{"id":"W4393227360","doi":"10.51559/myphje28","title":"Focus on the dabrafenib, vemurafenib, and trametinib in the clinical outcome of melanoma: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology Venereology and Aesthetic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Meta-analysis; Medicine; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Cancer research; Biology; MAPK/ERK pathway; Genetics","score_opus":0.11116023517452486,"score_gpt":0.3703861669011715,"score_spread":0.25922593172664665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393227360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018223358,0.9969716,0.00022384457,0.00021668838,0.000083747254,0.0001380735,0.0003791115,0.0000111144645,0.00015336872],"genre_scores_gemma":[0.08662835,0.9091969,0.0011276753,0.0010282724,0.00021619764,0.0007527585,0.00075544,0.000025778709,0.0002686877],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9898656,0.0043069655,0.0032065692,0.0010358616,0.0012335327,0.00035141368],"domain_scores_gemma":[0.97646993,0.017471138,0.0033464462,0.0004750153,0.0019404922,0.00029707956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015597619,0.0029128387,0.020026417,0.0080344835,0.0006702317,0.0035101122,0.0021907487,0.0021585554,0.0043028435],"category_scores_gemma":[0.034190565,0.0011758668,0.03947091,0.00891515,0.0006989098,0.0020754624,0.0016752102,0.0018227233,0.00032796615],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088522217,0.00002070789,0.0030756206,0.592536,0.39203563,0.00011707855,0.00009091517,0.0003318632,0.0001572222,0.00017221285,0.00070938125,0.009868183],"study_design_scores_gemma":[0.0002562541,0.00012574755,0.0030649498,0.056013413,0.93778795,0.00011542249,0.00006220167,0.00012102265,0.00008315053,0.00019444557,0.0021530103,0.000022396933],"about_ca_topic_score_codex":0.008606316,"about_ca_topic_score_gemma":0.020763734,"teacher_disagreement_score":0.020026417,"about_ca_system_score_codex":0.0031676348,"about_ca_system_score_gemma":0.005451053,"threshold_uncertainty_score":0.08248913},"labels":[],"label_agreement":null}]}